Anti-adipocyte scFv-Fc antibody suppresses subcutaneous adipose tissue development and affects lipid metabolism in minipigs

Applied Biochemistry and Biotechnology
M L ChengS Z Gao

Abstract

Anti-adipocyte monoclonal antibody has been shown to reduce body fat mass in animals. Here, we investigated the effects of an anti-adipocyte antibody (single-chain variable fragment and crystallizable fragment, scFv-Fc) on pig subcutaneous adipose tissue development and lipid metabolism. The scFv-Fc antibody did not alter feed intake or body weight of treated pigs. It suppressed subcutaneous adipose tissue development by reducing the percentage of larger adipocytes, which led to a reduction in body fat mass and subcutaneous adipose tissue thickness. Body fat mass was reduced by reducing triglyceride biosynthesis and promoting triglyceride lipolysis in adipose tissue. There was an increase in lipoprotein lipase mRNA expression in adipose tissue and activity in blood and an enhanced transportation of circulating high-density lipoprotein, low-density lipoprotein, and free fatty acids. Blood concentrations of triglyceride, total cholesterol, glucose, insulin, and adiponectin and mRNA expression of adiponectin in adipose tissue remained unaffected. These findings suggest that anti-adipocyte scFv-Fc antibody may have an application for reducing body fat mass in obese subjects.

References

Mar 1, 1992·Comparative Biochemistry and Physiology. Comparative Physiology·F Peréz-Llamas, S Zamora
Apr 1, 1992·Comparative Biochemistry and Physiology. Comparative Physiology·C Y HuN B Wehr
Apr 1, 1992·The International Journal of Biochemistry·A H Nassar, C Y Hu
Jan 1, 1991·Comparative Biochemistry and Physiology. A, Comparative Physiology·J DongC Y Hu
Jun 1, 1990·Proceedings of the Society for Experimental Biology and Medicine·J Killefer, C Y Hu
Jan 1, 1990·Reproduction, Nutrition, Development·J P DulorJ Nougues
May 1, 1995·Obesity Research·J T Wright, G J Hausman
Apr 29, 1998·Journal of the American Dietetic Association·S M ShickH Seagle
Nov 14, 1998·Biochemical and Biophysical Research Communications·D J Flint
Mar 27, 1999·Biochemical and Biophysical Research Communications·Y AritaY Matsuzawa
Jun 10, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·K HottaY Matsuzawa
May 10, 2001·The Journal of Clinical Endocrinology and Metabolism·C WeyerP A Tataranni
Feb 8, 2002·Journal of Animal Science·A D HigbieC J Monlezun
May 29, 2002·The Journal of Biological Chemistry·Naoto KubotaTetsuo Noda
Dec 18, 2003·The American Journal of Medicine·Vivian Fonseca
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·George A Bray
Jun 8, 2004·The Journal of Clinical Endocrinology and Metabolism·Scott M Grundy
Oct 4, 2005·Lancet·David W Haslam, W Philip T James

❮ Previous
Next ❯

Citations

Feb 22, 2014·Monoclonal Antibodies in Immunodiagnosis and Immunotherapy·Junko MuraokaYuji Ito
Apr 13, 2015·Applied Biochemistry and Biotechnology·Hanaa A Hassan, Nermin E El-Gharib
Oct 5, 2018·Frontiers in Immunology·Fernando CorvilloMargarita López-Trascasa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.